Academic Journal

Cook Zenith Alpha Endograft: A Protocol to Minimise Limb Graft Occlusion

التفاصيل البيبلوغرافية
العنوان: Cook Zenith Alpha Endograft: A Protocol to Minimise Limb Graft Occlusion
المؤلفون: Pini, Rodolfo, Bianchini Massoni, Caludio, Faggioli, Gianluca, Caputo, Stefania, Sufali, Gemmi, Ancetti, Stefano, Vacirca, Andrea, Gallitto, Enrico, Perini, Paolo, Freyrie, Antonio, Gargiulo, Mauro
المساهمون: Pini, Rodolfo, Bianchini Massoni, Caludio, Faggioli, Gianluca, Caputo, Stefania, Sufali, Gemmi, Ancetti, Stefano, Vacirca, Andrea, Gallitto, Enrico, Perini, Paolo, Freyrie, Antonio, Gargiulo, Mauro
سنة النشر: 2024
المجموعة: Università di Parma: CINECA IRIS
مصطلحات موضوعية: Cook Alpha, EVAR, Follow up, Iliac limb occlusion, Prevention
الوصف: Objective: Numerous articles have reported an increased incidence of limb graft occlusion (LGO) with the Cook Zenith Alpha endograft compared with other endografts in endovascular aortic aneurysm repair (EVAR). The present study aimed to assess the rate of LGO after EVAR in particular with the Cook Zenith Alpha device when adhering to a standardised protocol designed to prevent limb related complications. Methods: This was a non-sponsored retrospective study performed in two university vascular surgery centres employing the same protocol for limb complication prevention during EVAR from 2016 to 2019. The protocol encompassed: (1) angioplasty of any common/external iliac artery with > 50% stenosis before endograft navigation; (2) proximal sealing zone of limbs at the same level of the flow divider with minimum overlap, which is more restrictive than the Cook Zenith Alpha instructions for use; (3) semicompliant kissing ballooning of limbs; (4) limb stenting in case of any residual tortuosity/kinking/stenosis; and (5) adjunctive common and external iliac stenting for residual stenosis/dissection after EVAR. Patients enrolled in this study were treated with standard aorto-bis-iliac EVAR. Follow up was performed by clinical visit and duplex ultrasonography at discharge, six months, and yearly thereafter. The primary endpoint was to evaluate the LGO rate with different EVAR devices (Cook Zenith Alpha, Gore C3, and Medtronic Endurant) and to determine potential risk factors for LGO associated with the Zenith Alpha. Results: In the study period, 547 EVARs were considered: 233 (42.6%) Cook Zenith Alpha, 196 (35.8%) Gore Excluder, and 118 (21.6%) Medtronic Endurant. The mean follow up was 44 ± 23 months, and the five year freedom from LGO was 97 ± 3%, without differences between groups (97 ± 2%, 95 ± 3%, and 100% with Cook Zenith Alpha, Medtronic Endurant, and Gore Excluder, respectively; p = .080). In the Zenith Alpha group, intra-operative adjunctive iliac artery angioplasty, iliac artery stenting, or iliac limb ...
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:001386211800001; journal:EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY; https://hdl.handle.net/11381/2992073
DOI: 10.1016/j.ejvs.2024.06.036
الاتاحة: https://hdl.handle.net/11381/2992073
https://doi.org/10.1016/j.ejvs.2024.06.036
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.CF31791F
قاعدة البيانات: BASE
الوصف
DOI:10.1016/j.ejvs.2024.06.036